Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 8 , ISSUE 1 ( January-March, 2016 ) > List of Articles

REVIEW ARTICLE

Revisiting Cerebral Palsy: Pathogenesis and Management

Sharifah Sulaiha Aznal, Sivalingam Nalliah, Tong Wooi Chng

Citation Information : Aznal SS, Nalliah S, Chng TW. Revisiting Cerebral Palsy: Pathogenesis and Management. J South Asian Feder Obs Gynae 2016; 8 (1):57-65.

DOI: 10.5005/jp-journals-10006-1386

Published Online: 01-06-2013

Copyright Statement:  Copyright © 2016; The Author(s).


Abstract

PDF Share
  1. The epidemiology of the cerebral palsies. In: Levine M, Cgervenak F, editors. Fetal and neonatal neurology. 4th ed. Edinburgh: Churchill Livingstone Elsevier; 2009. p. 867-867.
  2. The definition and classification of cerebral palsy. Dev Med Child Neurol 2007;49 (Suppl 109):8-14.
  3. Lectures on deformity of the human frame. Lancet 1843;1:318-320.
  4. Intrapartum asphyxia: a rare cause of cerebral palsy. J Pediatrics 1988;112(4):515-519.
  5. Assessing the contribution of birth asphyxia to cerebral palsy in term singletons. Paediatric and Perinatal Epidemiology 1995;9(2): 156-170.
  6. Adverse obstetric events are associated with significant risk of cerebral palsy. Am J Obstet Gynecol 2010;203(4):328e1-328-e5.
  7. A systematic review of the role of intrapartum hypoxiaischemia in the causation of neonatal encephalopathy. Am J Obstet Gynecol 2008 Dec;199(6):587-595.
  8. The panorama of cerebral palsy in Sweden. XI. Changing patterns in the birth-year period 2003–2006. Acta Paediatrica 2014;103(6):618-624.
  9. Intrapartum asphyxia: a rare cause of cerebral palsy. J Paediatr 1988;113(2):4201
  10. Intrapartum hypoxic-ischemic cerebral injury and subsequent cerebral palsy, medico-legal issues. Pediatrics 1997;99(6):851-859.
  11. Prenatal and perinatal factors and cerebral palsy in low birth weight infants. J Paediatr 1996;128(3):407-414.
  12. Antenatal antecedents and the impact of obstetric care in the aetiology of cerebral palsy. Clinical Obstet Gynecol 2008;51(4): 775-786.
  13. Experimental biology of cerebral hypoxiaischemia: relation to perinatal damage. Paediatric Research 1990;27:317-326.
  14. The incidence of prenatal brain injury, neuropath. Appl Neurobiol 1991;17(2):29-38.
  15. Pathogenesis of cerebral white matter injury of prematurity: review. Arch Dis Child Fetal Neonatal Ed 2008;93(2):153-161.
  16. Who will deliver our grandchildren? Implications of cerebral palsy litigation. JAMA 2005;294(13):1688-1690.
  17. Causes and mechanisms of intrauterine hypoxia and its impact in fetal cardiovascular system: a review. Int J Paediatr. 2010; Available at: http://dx.doi.org/10.1155/2010/401323.
  18. Two patterns of perinatal brain damage and their conditions of occurrence. Am J Obstet Gynecol 1972;112(2): 246-276.
  19. Epo and other hematopoietic factors. Seminars in Fetal and Neonatal Medicine 2007; 12(4):250-258.
  20. Casecontrol study of antenatal and intrapartum risk factors in very preterm singleton babies. The Lancet 1995;346(8988): 1449-1454.
  21. Cerebral palsy in children with low birth weight. Arch Dis Childh 1963 Dec;38(202):579-588.
  22. Trends in the prevalence of cerebral palsy in a population based study. Paediatrics 2002;110(6):1220-1225.
  23. Outcome after ischemia in the developing sheep brain: electroenchephalic and histological study. Ann Neurol 1992;31(1):14-21.
  24. Cerebrovascular disorders: molecular isnights and therapeutic opportunities. Nature Neuroscience 2001:14(11):1390-1397.
  25. The changing panorama of cerebral palsy in Sweden. IX. Prevalence and origin in the birth-year period 1995-1998. Acta Paediatrica 2005;94(3):287-294.
  26. K, Cerebral palsy: classification and epidemiology. Phys Med Rehabil Clin N Am 2009;20(3):425-452.
  27. Cerebral palsy among term and post term births. JAMA 2010 Sep;304(9):976-982.
  28. Systemic inflammation and cerebral palsy risk in extremely preterm infants. J Child Neurol 2014;29(12):1692-1698.
  29. Twins, triplets, and cerebral palsy in births in Western Australia in the 1980s. BMJ 1993;307(6914):1239-1243.
  30. Comparison of risk factors for cerebral palsy in twins and singletons. Dev Med Neurol 2005;47(9):587-591.
  31. Long-term neurodevelopmental outcome in twin-to-twin transfusion syndrome. Am J Obstet Gynecol 2003 Nov;189(5):1314-1319.
  32. Perinatal infections and cerebral palsy. Minerva Ginecol 2007;59(2):151-157.
  33. Cerebral palsy in preterm infants: a population-based case-control study of antenatal and intrapartal risk factors. Acta Paediatr 2002;91(8):946-951.
  34. Preterm birth and cerebral palsy: is tumor necrosis factor the missing link? Dev Med Chil Neurol 1993;35(6): 1101-1106.
  35. Fetal exposure to an intraamniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000;182(3): 675-681.
  36. Neonatal risk factors for cerebral palsy in very preterm babies: case-control study. BMJ 1997;314(7078):404-408.
  37. Perinatal infections and cerebral palsy. Clin Perinatol 2006;33(2):315-333.
  38. Intrauterine infection and the development of cerebral palsy. BJOG 2003;110(20): 124-127.
  39. Trends in the prevalence of cerebral palsy in a population-based study. Pediatrics 2002;110(6):1220-1225.
  40. Genetic polymorphisms and cerebral palsy in very preterm infants. Pediatr Res 2005;57(4):494-499.
  41. Mutation in the AP4M1 gene provides a model for neuroaxonal injury in cerebral palsy. Am J Hum Genet 2009;85(1):40-52.
  42. Adaptor protein complex-4 (AP-4) deficiency causes a novel autosomal recessive cerebral palsy syndrome with microcephaly and intellectual disability. J Med Genet 2011;48(2):141-144.
  43. Cerebral palsy and congenital malformations. Eur J Paediatr Neurol 2008;12(2):82-88.
  44. Congenital anomalies in children with cerebral palsy: a population-based record linkage study. Dev Med Child Neurol 2010;52(4):345-351.
  45. Cerebral palsy in multiple births in Western Australia: genetic aspects. Am J Med Genet 1990;37(3):346-351.
  46. Cerebral palsy in Saudi Arabia: a case-control study of risk factors. Dev Med Child Neurol 1991;33(12):1048-1052.
  47. Congenital dopa-responsive disorders: a diagnostic and therapeutic challenge to the cerebral palsies? Dev Med Child Neurol 2007;49(2):85
  48. A template for defining a causal relation between acute intrapartum events and cerebral palsy: international consensus statement. BMJ 1999;319(7216): 1054-1059.
  49. Perinatal factors and cerebral palsy. Obstet Gynecol 2006;108(6):1499-505.
  50. Imaging for diagnosis and treatment of cerebral palsy. Clin obstet and Gynaecol 2008;51(4):787-799.
  51. A systematic review of neuroimaging for cerebral palsy. J Child Neurol 2008;23(2):216-227.
  52. Head ultrasound in NICU can predict cerebral palsy. Neurology Today 2008;8(23):1-10.
  53. Confidence in the prediction of neurodevelopmental outcome by cranial ultrasound and MRI in preterm infants. In: Archives of Disease in Childhood Fetal and Neonatal Edition 2010;95(6):F388-390.
  54. Hemodynamics of the cerebral arteries of infants with periventricular leukomalacia. Pediatrics 2006;116:1-8.
  55. Neuroimaging for cerebral palsy. J Child Neurol 2008;23(2):3-4.
  56. Determination of the timing of fetal brain damage from hypoxemia-ischemia. Am J Obstet Gynecol 2001 Jan;184(2):217-224.
  57. Mechanism of febrile seizure. Brain Dev 2010 Feb;32(2):170.
  58. Antenatal steroids may reduce adverse neurological outcome following chorioamnionitis: neurodevelopmental outcome and chorioamnionitis in premature infants. J Paediatr Child Health 2005;41(4): 186-190.
  59. Cerebral palsy: a neonatal perspective. Ann Ind Acad Neurol 2007;10(5):33-43.
  60. Prolonged indomethacin exposure is associated with decreased white matter injury detected with magnetic resonance imaging in premature newborns at 24 to 28 weeks’ gestation at birth. Pediatrics 2006 May;117(5):1626-1631.
  61. NICHD neonatal network. Adverse neurodevelopmental outcomes among extremely low birth weight infants with a normal head ultrasound: prevalence and antecedents. Pediatrics 2005;115(3):673-680.
  62. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus (Review). Cochrane Collaboration 2009.
  63. A randomized trial of magnesium sulphate for the prevention of cerebral palsy. NEJM 2008;359(9):895-905.
  64. Review: antenatal magnesium sulphate prevents cerebral palsy in preterm infants. Evid Based Med 2009 Oct;14(5):141.
  65. SOGC clinical practice guideline. Magnesium sulphate for fetal neuroprotection. J Obstet Gynaecol Can 2011 May;33(5):516-529.
  66. Selective head cooling with mild systemic hypothermia after neonatal hypoxic-ischemic encephalopathy: a multicenter randomized controlled trial in China. J Pediatr 2010 Sep;157(3):367-372.
  67. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev 2013 Jan 31;1:CD003311. Epub 2013 Jan 31.
  68. Canale, Campbell's Operative Orthopaedics, 12th ed. Chapter 33. Cerebral palsy.
  69. Jared Wilcox Fehlings. Stem cell treatments for cerebral palsy: Fact sheet for patients and families, February 2011.
  70. Update on stem cell therapy for cerebral pals. Expert Opin Biol Ther 2011 Apr;11(4):463-471.
  71. Hyperbaric oxygen for children with cerebral palsy: a randomised multicentre trial. The Lancet 2001 Feb;357(24):582-586.
  72. Therapeutic choices in the locomotor management of the child with cerebral palsy— more luck than judgement? Arch Dis Child 2001;85(4): 275-279.
  73. Selective dorsal rhizotomy: metaanalysis of three randomized controlled trials. Developmental Medicine and Child Neurology 2002;44(1):17-25.
  74. Cerebral palsy life expectancy. Clin Perinatol 2006 Jun;33(2):545-555.
  75. Regional variation in survival of people with cerebral palsy in the United Kingdom. Pediatrics 2005;116(6):1383
  76. Cerebral palsy: introduction and diagnosis (Part 1). J Pediatr Health Care 2007;21(3):146-152.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.